EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs.

C Austin Zamarripa, Ashley N Dowd, Harrison J Elder, Lauren Czaplicki, Dana Tfayli iD, Kriti Rastogi, Johannes Thrul, Justin C Strickland, Meghan B Moran, Tory R Spindle iD

Experimental and Clinical Psychopharmacology · 2025-04 · 33 (2) · 123-132

DOI: 10.1037/pha0000755 ↗

At a glance

Übersichtsarbeit in Experimental and Clinical Psychopharmacology, 2025-04. Written by C Austin Zamarripa and 9 co-authors. Institution: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine. Major MEDLINE topics: Nicotine, Tobacco Products, Smoking Cessation. Cited 35 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, National Institute on Drug Abuse/Food and Drug Administration Center for Tobacco Products.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Oral nicotine pouches (ONPs) are an emergent class of tobacco products that, unlike conventional oral smokeless tobacco products, contain a nicotine powder instead of tobacco leaves. This review synthesizes available data on ONPs in key research domains including survey studies, marketing/advertising studies, chemical characterization and in vitro studies, and clinical studies. Research findings relevant for ONP regulations are summarized, including who uses these products and why, how marketing tactics influence appeal and use intentions, what harmful and potentially harmful constituents they contain, and what acute effects they have on humans. Taken together, the current data suggest that ONPs likely produce less harm to individual users than conventional tobacco products (e.g., moist snuff, cigarettes) and can acutely suppress nicotine/tobacco withdrawal symptoms among current cigarette smokers. Thus, ONPs may be a viable harm reduction option for individuals who switch completely to using them from conventional products. However, randomized controlled trials are needed to determine if established tobacco users would use ONPs long term, and more independent academic research is needed given that most ONP studies to date are tobacco industry-funded. Additionally, ONPs have qualities (e.g., flavors, marketing claims of "tobacco free") that could increase appeal among youth and young adults, and these products can deliver nicotine at levels sufficient to cause dependence; widespread adoption of ONPs among otherwise nicotine-naive individuals may reduce their net public health benefit. This review concludes by suggesting future research directions necessary to increase scientific understanding of ONPs and inform regulations for these increasingly popular products. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Subjects

MeSH terms (MEDLINE)

NicotineTobacco ProductsSmoking CessationHumansTobacco, SmokelessAdministration, Oral

Substances

Nicotine

Authors and institutions

  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
  • Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health.
  • Department of Mental Health, Johns Hopkins Bloomberg School of Public Health.

ORCID profiles: Dana Tfayli, Tory R Spindle

Funding

  • NIDA NIH HHS
  • National Institute on Drug Abuse/Food and Drug Administration Center for Tobacco Products

Cite

APA

Zamarripa, C. A., Dowd, A. N., Elder, H. J., Czaplicki, L., Tfayli, D., Rastogi, K., Thrul, J., Strickland, J. C., Moran, M. B., & Spindle, T. R. (2025). A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs. Experimental and Clinical Psychopharmacology, 33(2), 123-132. https://doi.org/10.1037/pha0000755

Vancouver

Zamarripa CA, Dowd AN, Elder HJ, Czaplicki L, Tfayli D, Rastogi K, et al. A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs. Experimental and Clinical Psychopharmacology. 2025;33(2):123-132. doi:10.1037/pha0000755

BibTeX
@article{Zamarripa2025,
  author = {Zamarripa, C Austin and Dowd, Ashley N and Elder, Harrison J and Czaplicki, Lauren and Tfayli, Dana and Rastogi, Kriti and Thrul, Johannes and Strickland, Justin C and Moran, Meghan B and Spindle, Tory R},
  title = {A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2025},
  volume = {33},
  number = {2},
  pages = {123--132},
  doi = {10.1037/pha0000755}
}
Start for free →